Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Okay??? I'm not sure I'm getting the point of the story, but thanks.
rum
Just wishful thinking here or dreamin'(where is dreamer), but could Blackstone be to an as yet unnamed company what Ackman was to Valeant in their pursuit of Allergen?
Obviously Ariad would have to be okay with the potential transaction since they gave Blackrock the exemption, but it allows the unnamed company to acquire shares "on the cheap."
rum
rurik, you may be right, but I would consider that a disappointing move. I'm ready for something definitive to happen, even if it's something I wouldn't select. It's time to move on to something one way or the other.
rum
I'm guessing that this filing will highlight exactly what the Rights Agreement really is all about. It's pure BS and has nothing to do with protecting NOL's. It's all about preventing a buyout.
2da, I have to agree that this signals one of two things, either they are doing an equity raise with Blackrock, or Blackrock is being used by an acceptable suitor to acquire shares before a formal offer.
I think the market would prefer that Ariad sell and the equity raise would be less favorable. Considering this filing was at the end of the day, I'm guessing it's an equity raise. Of course it could be something totally different that we hadn't considered.
rum
PS I'm getting a bit tired of this too. Also, while an equity raise would be dilutive, I think once it's done, the company starts a bunch of trials and the share price will react favorably.
"...time period between asco and august hopefully we will be close to 10.00 I have no confidence in the stock anymore..."
Wow, that's about a 55% move up during the coming 3 months. Give us a list of the companies you have confidence in.
Just joking, thesaud. I hope you are well.
rum
ARIAD Pharmaceuticals, Inc. (the “Company”) extended the terms of employment until December 31, 2016 for each of its executive officers other than Harvey J. Berger
Anyone read anything into this action?
rum
aura, I'm not really certain, but I believe if Ariad was to file for an offering I think they would need to disclose just about everything. Once it's public I would guess that insiders could participate.
I agree 100% with 2da. A decent size purchase by HB would go a long way to restoring confidence. It might even quiet those that point to HB's misstatement that he would be a buyer of Ariad stock while he was in fact selling.
rum
Vid, I'm not really sure, but I believe Ariad's Beta is based on its volatility vs the S&P not vs IBB or any of the biotech indices.
rum
Isn’t Waxman’s method a form of government intervention?
Yes, that was the point I was attempting to make (albeit a poor attempt).
I did follow the link to your previous message on the subject and was unaware of Waxman's ulterior motive.
Thx for the clarification.
This method of controlling drug costs seems to me to be a better alternative than Government intervention.
http://www.latimes.com/business/money/la-fi-mo-hepatitis-c-gilead-pricing-20140321,0,3617096.story#axzz2xrdakvlb
POM, your opinion is just as good as mine or any other's opinion. My only comment would be that if I shared your opinions, I probably wouldn't be long in the stock.
I would also love to see a strong buyout number, but I don't believe that is in the cards right now.
As for his ego, he wouldn't have lasted nearly this long without the ego. He'd have folded long ago.
Where's the money going to come from? Your guess is as good as mine. It will come from somewhere or the dreams of a buyout will come true (but it won't be for the numbers being tossed around here).
rum
are bergerkings thought process really to blame for no discussions (shame, if thats true)?
POM, there's no question that a quick buyout would be preferred by many here. But isn't it possible that Berger sees better things for the company and better long term value for shareholders as a stand alone company.
If the buyout advocates had their way we would have been sold many times at much lower prices than we trade at today.
Personally, it's my opinion that Berger will not sell in the near future. If his motives are flawed, he will get some very vocal dissension from the new Board member. That will tend to make his life a little less pleasant and may change his thinking.
rum
My perspective, and not all agree, is that partnering is dilutive.
2da, that's not only your perspective...partnering is absolutely dilutive.
rum
Vid, I think Jesspro's suggestion is a very good one. You'll be doing the patient and his wife a service and not promoting either drug. If you believe it's necessary, you could tell them your circumstances of being an investor, but I really don't think it is ethically necessary. I'd have a different opinion if you were simply promoting 113.
Jesspro said:
If somebody tells the wife to ask her husband's oncologist the adverse effects and efficacy of the 3 drugs currently in trial, it will not be construed as being biased since you are not even mentioning/promoting 113 and the third competition. 113 and the 3rd drug have the same ORR which is better than what her husband is using and no extreme SE. 113 is the only one that has a notable response in brain mets.
Vid, you'd make a lousy politician...way too honest.
We need more government to keep us all safe.
rum
IMO many of those that have set a target to sell their position will change that target as the price rises. When the price got beaten down to $6ish many were willing to get out for $9-10. When the price later fell to the $2's many were wanting to get out around $6. I suspect many of those same long-term holders are still here (and good for them). This is no knock on those people, it's human nature in the stock market world.
rum
2da...
I'm trying not to complain about it.
Too late! I hope all is well.
rum
Thanks III man. I hadn't heard from you since their earnings came out and disappointed a bit.
All the best,
rum
Hey III man, have you given up on ASTC?
All the best,
rum
thesaud
Great news!!!
rum
It looks like the news is simply a mention at http://www.AnalystsReview.com/register
rum
maven, I agree 100%. I also believe that while 113 is promising, Iclusig is a very powerful and valuable drug. The October fiasco was a result of politics and political missteps. Iclusig never should have been pulled. The FDA actions were obviously harmful to Ariad, but the setback to patients should be a crime (literally).
rum
After the October fiasco, some of us only have optimism and hope left.
rum
Vid and 2da, I don't disagree with your desired sale of the company, but if I'm not mistaking, many of us were hoping for a $6 buyout when aria was around $4 and then after the second shoe dropped were hoping for a $4-5 buyout when aria was in the 2's.
Perhaps a continued recovery would be the better route, albeit more of a long-term view.
rum
Good call, micanwait. I'm glad I had no one to make a bet with. I could have lost a bundle.
rum
Jesspro, I think you're correct although I don't think HB welcoming Denner to the BOD was ever in the cards. HB will fight tooth and nail to avoid that.
I wonder if Denner was instrumental in getting Icahn to invest in Forest Labs?
rum
Adam Feurstein is a piece of crap. The Street.com is BS. When will the SEC get the stones to do something about these low-lives. He should share a cell with that good-for-nothing Cramer, a self promoter of the worst kind.
CNBC has the biggest bunch of losers. Who wants to hear from some former automobile exec that helped run GM into the ground or an airline exec that presided over destroying his company?
These conferences aren't usually the forum for big news. But, there's a first time for everything.
rum
For those speculating that something is up...buyout coming...new molecule to be announced soon...news coming Monday
Look at the post (by justthefacts1) to which I am responding. IMO this news would account for 100% of the activity in Friday's trading.
That's it, although I believe this news is very positive for shareholders.
rum
Corrupt...No
Rubber Stamp...Yes
We can just disagree.
rum
lax, you are 100% right, technically. But when you have a Board where the members would not dare visit the Men's Room without clearing it with the Chairman, reality takes a different path. You can bet the only input regarding option awards came from HB and HB alone.
Don't get me wrong, I appreciate many of HB's talents, but he is fully in charge.
rum
This makes little sense. "CEO Ian Read confirms Pfizer buyout of Ariad Pharmaceuticals in official PR coming Friday, January 31st" I believe that would violate SEC rules.
In this same article by Sierra World it says, "it is a prediction so nothing is confirmed"
Come on, they get a confirmation from the purchasing CEO, but nothing is confirmed.
I think Sierra World (if this is accurate) has gone over the line by mentioning their source. Either they are on thin ice or Ian Read is on thin ice.
rum
As a human being, AF falls into the same category as Jim Cramer. AF would probably take that as a complement, but I would assure him that I am in no way complementing him.
rum
I'm hoping the price rise will start a play for Ariad now so Harvey can retire.
I'm hoping the price rise will start a play for Ariad so I can retire.
rum
Has anyone noticed that the FDA announcement and today news both came on options expiration date. As someone that messes around with Ariad options, find it odd. Perhaps just a coincidence?
rum
2da, your common sense will be greatly missed. Thanks for doing such a good job.
Your friend,
rum
Vid: I don't know about the various conspiracy theories out there. In fact, I don't believe most of them. What I do believe was improper is the one theory that can be prosecuted.
The trading in the stock prior to the original announcement in October and then again prior to the reinstatement announcement clearly was a result of insider information.
I have been a part of 2 insider trading situations in the past (I did nothing wrong in either case, but the SEC did take action against a party in at least one of them). I can tell you this, they respond to complaints by shareholders that are harmed and they are very thorough in their investigation of those they believe may have been involved. In one of the cases I was involved in, it was just one harmed shareholder (that I was aware of) that made the complaint to the SEC.
Also, if they do investigate, you may never know about it unless they end up settling or fine someone a large amount that they want to brag about.
While the guilty party will be fined, the harmed shareholders get nothing.
rum
I think the statement by the FDA that speaks volumes is, “This marketing suspension brought everyone to the table to discuss the data and work to identify a patient population in which the drug’s benefit outweigh the risks,” Yao said.
Someone didn't want to come to the table and the FDA's actions encouraged them to do so.
rum
That red cloud could be the cloud of tax loss selling, but I prefer to see it as the FDA's Christmas present to faithful Ariad shareholders.
rum
I-man, I didn't act on the stock you mentioned to me. Now I've hurt my knee from kicking myself in the ass.
I will vote Harvey Berger for the greatest CEO of all time if his legal team takes actions against the FDA.
In my opinion, there isn't a chance on earth that Ariad would take any action against the FDA. It would be Ariad's version of the nuclear option. If they did that, they should close the doors and shut off the lights.
The chance of them taking action against any of the other parties that many of you are hoping for is not much higher. Ariad will stick to their mission which doesn't include filing lawsuits for actions that are next to impossible to prove.
Vid, your post regarding what the future holds for Ariad (# 41305) makes good sense to me. You (and I) should be glad HB isn't selling. It sux to wait, but we will be rewarded, IMO. However, as you indicated, the next couple of weeks may best be described as an opportunity, ie. lower pps. due to tax loss selling.
rum